Initial clinical experience with durvalumab plus tremelimumab in patients with unresectable hepatocellular carcinoma in realworld practice.
Oncol Lett
; 28(2): 397, 2024 Aug.
Article
in En
| MEDLINE
| ID: mdl-38979550
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Oncol Lett
Year:
2024
Document type:
Article
Affiliation country:
Japón
Country of publication:
Grecia